DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
The Dark Side of Med Device Kickbacks
Today, we're discussing a critical issue for pharmaceutical and medical device marketers – promotional compliance.
Overview of the Innovasis Settlement:
Innovasis Inc. recently settled a $12 million case for alleged kickback schemes to doctors. This highlights the importance of promotional compliance.
Allegations Against Innovasis:
From Jan. 1, 2014, to Dec. 31, 2022, Innovasis allegedly provided improper remuneration to surgeons, inducing them to use their products. These remunerations included consulting fees, IP acquisition fees, travel, and lavish events.
Implications for Compliance Practices:
Regulatory bodies like the FDA and DOJ are closely monitoring promotional practices. Companies must ensure both effectiveness and compliance in their marketing strategies.
Key Strategies for Compliance:
Transparency and documentation are vital in all interactions with healthcare professionals. Training and education are essential to understand boundaries, and internal audits help identify and rectify compliance issues early.
Conclusion:
Compliance safeguards reputation and builds trust. For assistance with compliance strategy, contact the Kulkarni Law Firm.
